Skip to content
2000
Volume 11, Issue 8
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Small molecular weight substances are functional, as neurotrophic factors can be developed as therapeutic drugs to treat neurodegenerative disorder. Recently, a large number of natural and synthetic neuritogenic compounds have been discovered. These compounds have various structural features, including terpenoids, lipids, alkaloids, steroid glycosides, small molecular peptides, and so on. Some of them possess not only neurotrophic properties but also neuroprotective activities. The structure-activity relationships (SARs) and mechanism of action of some important compounds have been studied intensively. Increasing experimental evidence suggests that several of these compounds can be promising candidates for drug development.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955711796268796
2011-07-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955711796268796
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test